Viewing Study NCT01665794


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-02-25 @ 10:03 PM
Study NCT ID: NCT01665794
Status: COMPLETED
Last Update Posted: 2025-12-22
First Post: 2012-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: University of Chicago
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module